Diabetes News

Women who experienced complications during pregnancies that occurred prior to kidney donation were at increased risk for developing hypertension and diabetes up to 27 years after donation.

Just 7.4% of U.S. adults met the Institute of Medicine’s recommended daily adequate intake of 14 g of fiber for every 1,000 kcals, data from a recent 5-year period show.

The NIH recently launched a new study to learn more about glucose changes during pregnancy.

Treatment with the mineralocorticoid receptor antagonist finerenone reduced the risk for new-onset AF or flutter by 29% compared with placebo in adults with diabetic kidney disease, according to new data from the FIDELIO-DKD trial.

Novo Nordisk announced a voluntary recall of select insulin product samples that were stored at temperatures below storage requirements, according to a company press release.

Only 12% of women who met the American College of Obstetricians and Gynecologists’ criteria for early gestational diabetes screening actually received it at a New York hospital, researchers reported.

Investigators found the diabetic kidney disease progression test KidneyIntelX, by RenalytixAI plc, successfully risk stratified a large cohort of patients for disease progression, according to a press release.

Between 2007 and 2016, researchers observed that use of metformin and newer glucose-lowering medications increased significantly for patients with chronic kidney disease and type 2 diabetes.

The FDA granted breakthrough therapy designation for TTP399 as an adjunctive therapy to insulin for the treatment of type 1 diabetes, according to a press release from vTv Therapeutics.

A test that incorporates plasma biomarkers was successful in predicting kidney function decline in patients with type 2 diabetes, a speaker reported.